We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$3.64B
AUM Growth
+$1.11B
Cap. Flow
+$1.01B
Cap. Flow %
27.59%
Top 10 Hldgs %
15.73%
Holding
482
New
187
Increased
74
Reduced
47
Closed
168

Top Buys

Rank Stock Value
1
BLMN icon
Bloomin' Brands
BLMN
+$58.4M
2
NFLX icon
Netflix
NFLX
+$32.1M
3
PFE icon
Pfizer
PFE
+$31.6M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$29.6M
5
XRAY icon
Dentsply Sirona
XRAY
+$29.5M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$36.5M
2
NRF
NorthStar Realty Finance Corp.
NRF
+$34.5M
3
RRC icon
Range Resources
RRC
+$33.3M
4
PCP
PRECISION CASTPARTS CORP
PCP
+$26.9M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 13.3%
2 Industrials 13.08%
3 Financials 11.22%
4 Energy 7.46%
5 Consumer Staples 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PETX
276
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.5M 0.04%
+80,893
New +$1.62M
BIOA
277
DELISTED
BioAmber Inc.
BIOA
$1.47M 0.04%
128,109
-16,891
-12% -$200K
DRNA
278
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.41M 0.04%
+50,000
New +$1.86M
RXDX
279
DELISTED
Ignyta, Inc.
RXDX
$1.4M 0.04%
+168,578
New +$1.58M
SBY
280
DELISTED
Silver Bay Realty Trust Corp.
SBY
$1.31M 0.04%
+84,290
New +$1.34M
NGNE icon
281
Neurogene
NGNE
$712M
$1.28M 0.04%
+5,015
New +$1.29M
QTWO icon
282
Q2 Holdings
QTWO
$3.92B
$1.25M 0.03%
+80,447
New +$1.24M
DG icon
283
CALL
Dollar General
DG
$27.9B
$1.25M 0.03%
+22,500
New +$1.31M
AMPE
284
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1.24M 0.03%
+650
New +$1.54M
CBIO
285
Crescent Biopharma
CBIO
$626M
$1.23M 0.03%
+752
New +$910K
LAND
286
Gladstone Land Corp
LAND
$360M
$1.19M 0.03%
+83,992
New +$1.16M
STAY
287
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$1.19M 0.03%
52,047
-125,453
-71% -$3.14M
GEVA
288
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$1.18M 0.03%
+14,249
New +$1.32M
JNPR
289
DELISTED
Juniper Networks
JNPR
$1.16M 0.03%
+44,957
New +$1.17M
BRDR
290
DELISTED
BODERFREE INC COM
BRDR
$1.16M 0.03%
+62,024
New +$1.17M
ARGS
291
DELISTED
Argos Therapeutics, Inc.
ARGS
$1.15M 0.03%
+5,729
New +$1.15M
KFN
292
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
$1.1M 0.03%
94,830
+38,295
+68% +$468K
CYTK icon
293
CALL
Cytokinetics
CYTK
$10.4B
$1.04M 0.03%
65,789
-328,947
-83% -$2.98M
SNDK
294
CALL
DELISTED
SANDISK CORP
SNDK
$1.02M 0.03%
+12,600
New +$930K
AGTC
295
DELISTED
Applied Genetic Technologies Corporation
AGTC
$999K 0.03%
+66,579
New +$983K
DAL icon
296
CALL
Delta Air Lines
DAL
$60.1B
$977K 0.03%
+28,200
New +$907K
ANIP icon
297
ANI Pharmaceuticals
ANIP
$1.78B
$969K 0.03%
+30,907
New +$820K
EEM icon
298
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$923K 0.03%
+22,500
New +$883K
AA icon
299
Alcoa
AA
$13.2B
$901K 0.02%
+29,130
New +$810K
RLJE
300
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$892K 0.02%
66,667
– –
10 11
12
13 14

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2014 Portfolio in Review

As of Q1 2014, Alyeska Investment Group held 482 positions worth $3.64B, up 44% from $2.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $1.01B of net new capital in Q1 2014, opening 187 new positions and adding to 74 existing holdings. Its largest new stake was Netflix: 5,600,000 shares worth $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was NorthStar Realty Finance Corp., an estimated $34.5M trimmed.

  • Alyeska Investment Group's largest Q1 2014 buy was Netflix: 5,600,000 shares worth $28.2M.
  • Alyeska Investment Group added most to Bloomin' Brands in Q1 2014, an estimated $58.4M increase.
  • Alyeska Investment Group's biggest Q1 2014 reduction was NorthStar Realty Finance Corp., cutting an estimated $34.5M.
  • Alyeska Investment Group fully exited 3M in Q1 2014, selling an estimated $36.5M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $3.64B portfolio in Q1 2014.
  • Alyeska Investment Group opened 187 new positions and closed 168 in Q1 2014.
  • Alyeska Investment Group's portfolio value rose 44% quarter-over-quarter to $3.64B.

Based on Alyeska Investment Group's 13F filing for Q1 2014, filed 15 May 2014.